HGH Systèmes Infrarouges SAS

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

HGH Systèmes Infrarouges SAS - overview

Established

1982

Location

-, -, France

Primary Industry

Electronics

About

HGH Systèmes Infrarouges SAS is a French company specializing in advanced electro-optical devices, focusing on infrared and visible testing technologies for various sectors, including defense and industrial applications. Founded in 1982 in France, HGH Systèmes Infrarouges SAS designs and provides advanced electro-optical solutions. The company was acquired by Carlyle Group and its management in September 2018, solidifying its operational strategies and client focus. The founder, Troiditheobao ngaythangqua, has a history of involvement in the industry, contributing to HGH's direction.


The company operates globally, with a notable headquarters in France and a focus on serving clients in North America, Europe, and Asia. HGH Infrared Systems specializes in the design and provision of advanced electro-optical devices and solutions, focusing on infrared and visible testing technologies. Their core products include blackbodies, integrating spheres, collimators, and integrated test benches, alongside sophisticated electro-optical testing software. These products serve various sectors, particularly in defense and military applications for night vision device testing and maintenance, as well as industrial applications in cement, metallurgy, and waste-to-energy.


In the most recent fiscal year 2024, HGH Infrared Systems reported a revenue of USD 18. 46 mn and an EBITDA of USD 3. 45 mn. The company's business model centers around B2B sales, often involving multi-year contracts for their advanced products and solutions, including the Spynel range and electro-optical test systems, reflecting a structured approach to client engagement and service delivery.


HGH Systèmes Infrarouges SAS is actively pursuing growth through new product launches and geographic expansion. The company aims to introduce innovative solutions tailored to meet the evolving needs of defense and industrial markets. Recent funding, resulting from a deal completed in September 2018, will facilitate this expansion and support the development of their upcoming product lines. Specifically, the company is targeting market penetration in Asia and North America by 2025, leveraging their established capabilities and global presence.


Current Investors

Carlyle Group

Primary Industry

Electronics

Sub Industries

Defence, Electronic Components

Website

www.hgh-infrared.com/

Verticals

Manufacturing

Company Stage

Mature - Buyout

Total Amount Raised

Subscriber access only

HGH Systèmes Infrarouges SAS - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedHGH Systèmes Infrarouges SAS-
Trade SaleCompletedChannel Technologies Group-

Displaying 1 - 2 of 2

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.